{"id":"W2997703943","doi":"10.1186/s12885-019-6442-2","title":"A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01","year":2019,"lang":"en","type":"article","venue":"BMC Cancer","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":153,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université Laval; BC Children's Hospital; Izaak Walton Killam Health Centre; Alberta Children's Hospital; University of Calgary; McGill University; University of British Columbia; Hospital for Sick Children; Université de Montréal; Montreal Children's Hospital; Centre hospitalier universitaire de Québec; Dalhousie University; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Institutes of Health Research","keywords":"Trametinib; Medicine; Neurofibromatosis; MAPK/ERK pathway; Refractory (planetary science); Glioma; Cancer research; Internal medicine; Oncology; Neurofibroma; Pathology; Signal transduction; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001787367,0.001856194,0.001615735,0.0005181385,0.0004500579,0.0009405607,0.001164309,0.001801332,0.004121226],"category_scores_gemma":[0.0009341639,0.0006260536,0.001546142,0.0005102052,0.0007993204,0.000980556,0.0003652911,0.003606234,0.0009115362],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001267852,"about_ca_system_score_gemma":0.002652079,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001497232,"about_ca_topic_score_gemma":0.003892746,"domain_scores_codex":[0.9995771,0.0001698228,0.00001838287,0.0000711708,0.00004755895,0.0001160325],"domain_scores_gemma":[0.9992387,0.00009953875,0.0001615592,0.00005571181,0.0000601568,0.0003843386],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6667787,0.1512704,0.01475925,0.001726463,0.002093635,0.001149768,0.0006406268,0.00463378,0.05011221,0.000754101,0.009636103,0.0964449],"study_design_scores_gemma":[0.597688,0.3815775,0.01133166,0.00004025692,0.0003707481,0.0009374383,0.0000801233,0.001277698,0.002910241,0.0001740973,0.003579526,0.0000327689],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9898816,0.001120058,0.0004814927,0.0005709928,0.000087685,0.004711533,0.001758827,0.00007212131,0.001315692],"genre_scores_gemma":[0.979146,0.002018998,0.002726129,0.001372523,0.0001595765,0.007438531,0.004222933,0.00003829299,0.002877078],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004121226,"threshold_uncertainty_score":0.01378685,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02066568916908531,"score_gpt":0.2824107083923213,"score_spread":0.261745019223236,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}